Search

Your search keyword '"Knipe, Jay O."' showing total 36 results

Search Constraints

Start Over You searched for: Author "Knipe, Jay O." Remove constraint Author: "Knipe, Jay O."
36 results on '"Knipe, Jay O."'

Search Results

3. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

5. Alicyclic Isoxazolinone Antibacterial Agents

7. Discovery of BMS-961955, an allosteric inhibitor of the hepatitis C virus NS5B polymerase

8. Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virus

9. Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond Donor

10. Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies

12. Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing

13. HCV NS5A replication complex inhibitors. Part 2: Investigation of stilbene prolinamides

14. Preclinical Characterization of BMS-791325, an Allosteric Inhibitor of Hepatitis C Virus NS5B Polymerase

15. The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

16. Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

17. Hepatitis C Virus NS5A Replication Complex Inhibitors: The Discovery of Daclatasvir

18. Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons

20. Biaryl isoxazolinone antibacterial agents

23. Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity

24. Hepatitis C Virus NS5A ReplicationComplex Inhibitors.Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotypewith Inhibitory Activity Toward Genotypes 1a and 1b Replicons.

31. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.

Catalog

Books, media, physical & digital resources